Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered CD27-related T cell subsets reflect immune imbalance in systemic lupus erythematosus. | Immunol Res | 2025 | 40381105 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for sepsis: advancing from evidence to innovative drug discovery. | Crit Care | 2025 | 40375087 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
| Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy. | Front Immunol | 2025 | 40370457 | PubTator, text mining | PubMed |
| Prognostic and diagnostic value of PVR gene and protein levels, serum amylase, and urinary IGFBP-7 and TIMP-2 biomarkers in multiple myeloma. | BMC Cancer | 2025 | 40369504 | PubTator, text mining | PubMed |
| Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus. | Sci Rep | 2025 | 40312552 | PubTator, text mining | PubMed |
| Novel diagnostic biomarker and immune profiling of GPR56+ B cell subsets in systemic lupus erythematosus. | Int Immunopharmacol | 2025 | 40311320 | PubTator, text mining | PubMed |
| Integrated Analysis of Intersecting Neutrophil Signatures in Behçet's Disease and Inflammatory Bowel Disease. | Int J Rheum Dis | 2025 | 40257285 | PubTator, text mining | PubMed |
| Cytokine Expression and Cytolytic Effect of Natural Killer Cells are Suppressed in Septic Shock. | Scand J Immunol | 2025 | 40254928 | PubTator, text mining | PubMed |
| Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma. | Front Oncol | 2025 | 40231264 | PubTator, text mining | PubMed |
| The stage- and subgroup-specific impact of non-HLA polymorphisms on preclinical type 1 diabetes progression. | Heliyon | 2025 | 40196768 | PubTator, text mining | PubMed |
| PVR exposure influences the activation, adhesion, and protein expression of human CD8+ T cells, including the CD96-mediated transfer of PVR. | J Immunol | 2025 | 40073261 | PubTator, text mining | PubMed |
| Monocytes from patients with myelodysplastic syndrome inhibit natural killer cell-mediated antitumor function through the CD200/CD200R pathway. | Int Immunopharmacol | 2025 | 40049088 | PubTator, text mining | PubMed |
| A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells. | J Exp Clin Cancer Res | 2025 | 40045373 | PubTator, text mining | PubMed |
| Mapping the nanoscale organization of the human cell surface proteome reveals new functional associations and surface antigen clusters. | bioRxiv | 2025 | 40027624 | PubTator, text mining | PubMed |
| Immune Checkpoint Receptor Expression Profiles of MAIT Cells in Moderate and Severe COVID-19. | Scand J Immunol | 2025 | 39980239 | PubTator, text mining | PubMed |
| The imbalance of follicular helper T cells and follicular regulatory T cells is involved in renal injury in active lupus nephritis. | Hum Immunol | 2025 | 39954558 | PubTator, text mining | PubMed |
| Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential. | mBio | 2025 | 39918313 | PubTator, text mining | PubMed |
| Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma. | Cancer Immunol Immunother | 2025 | 39904787 | PubTator, text mining | PubMed |
| CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment. | J Leukoc Biol | 2025 | 39901844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=10